The University of Genoa, known also with the acronym UniGe, is one of the largest universities in Italy. It is located in the city of Genoa and regional Metropolitan City of Genoa, on the Italian Riviera in the Liguria region of northwestern Italy. The original university was founded in 1481.

During the past decade, Università degli studi di Genova conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 5 clinical trials were completed, i.e. on average, 31.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Università degli studi di Genova" #1 sponsor was "University of Genova" with 6 trials, followed by "Boehringer Ingelheim" with 4 trials sponsored, "Associazione Qol-one" with 2 trials sponsored, "Campus Bio-Medico University" with 2 trials sponsored and "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 2 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Università degli studi di Genova" #1 collaborator was "University of Genova" with 4 trials as a collaborator, "European Commission" with 3 trials as a collaborator, "European Society of Anaesthesiology" with 3 trials as a collaborator, "University of Padova" with 3 trials as a collaborator and "Universita degli Studi di Genova" with 2 trials as a collaborator. Other collaborators include 59 different institutions and companies that were collaborators in the rest 69 trials.

According to Clinical.Site data, the most researched conditions in "Università degli studi di Genova" are "Multiple Sclerosis" (3 trials), "Acute Myeloid Leukemia" (2 trials), "Acute Respiratory Failure" (2 trials), "Breast Cancer" (2 trials) and "HIV Infections" (2 trials). Many other conditions were trialed in "Università degli studi di Genova" in a lesser frequency.

Most popular intervention types in "Università degli studi di Genova" are "Drug" (27 trials), "Other" (7 trials), "Procedure" (6 trials), "Device" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Ultrasound" (3 trials), "Best Supportive Care" (2 trials), "Nintedanib" (2 trials) and "3D mammography (Tomosynthesis)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Università degli studi di Genova" are 44 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Università degli studi di Genova". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Università degli studi di Genova, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Università degli studi di Genova, 2 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 10 trials that are defined as “Not Applicable".

Università degli studi di Genova has several departments that took part in Clinical trials: "Clinica Ematologica - Università degli Studi" - 13 trials, "Clinica Ematologica - DiMI - Università degli Studi di Genova" - 12 trials, "Department of Cardiology, Ospedali del Tigullio" - 3 trials, "Ortohdontic Department - Univesity of Genoa" - 2 trials